BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 19995490)

  • 1. One-stage tubeless antegrade ureteric stenting: a safe and cost-effective option?
    Chitale S; Raja V; Hussain N; Saada J; Girling S; Irving S; Cockburn JF
    Ann R Coll Surg Engl; 2010 Apr; 92(3):218-24. PubMed ID: 19995490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. To tube or not to tube? Utilising a tubeless antegrade ureteric stenting system in a tertiary referral hospital.
    Looney AT; Daly PJA; Cullen IM; MacMahon P; Kelly IMG
    Ir J Med Sci; 2019 Feb; 188(1):283-288. PubMed ID: 29696559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The management of ureteric obstruction secondary to malignant pelvic disease.
    Chitale SV; Scott-Barrett S; Ho ET; Burgess NA
    Clin Radiol; 2002 Dec; 57(12):1118-21. PubMed ID: 12475538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A review of antegrade stenting in the management of the obstructed kidney.
    Sharma SD; Persad RA; Haq A; Appleton DS; Doyle PT; Bullock KN; Doble A
    Br J Urol; 1996 Oct; 78(4):511-5. PubMed ID: 8944505
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Direct primary or secondary percutaneous ureteral stenting: what is the most compliant option in patients with malignant ureteral obstructions?
    Carrafiello G; Laganà D; Lumia D; Giorgianni A; Mangini M; Santoro D; Cuffari S; Marconi A; Novario R; Fugazzola C
    Cardiovasc Intervent Radiol; 2007; 30(5):974-80. PubMed ID: 17468910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antegrade retrieval of ureteral stents through an 8-French percutaneous nephrostomy route.
    Liang HL; Yang TL; Huang JS; Lin YH; Chou CP; Chen MC; Pan HB
    AJR Am J Roentgenol; 2008 Nov; 191(5):1530-5. PubMed ID: 18941096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is the routine check nephrostogram following percutaneous antegrade ureteric stent placement necessary?
    Soh KC; Tay KH; Tan BS; Mm Htoo A; Hg Lo R; Lin SE
    Cardiovasc Intervent Radiol; 2008; 31(3):604-9. PubMed ID: 17710479
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved method of double-J ureteric stenting.
    H'ng MW; Ilin L; Wong KP
    J Med Imaging Radiat Oncol; 2013 Apr; 57(2):198-201. PubMed ID: 23551778
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Predictors of antegrade ureteral stenting failure: a single-center experience in patients with malignant and benign ureteral obstruction.
    Nas OF; Oztepe MF; Kandemirli SG; Bilgin C; Ozkaya G; Inecikli MF; Kaygısız O
    Abdom Radiol (NY); 2021 May; 46(5):2188-2194. PubMed ID: 33226456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary antegrade ureteric stenting: prospective experience and cost-effectiveness analysis in 50 ureters.
    Watson GM; Patel U
    Clin Radiol; 2001 Jul; 56(7):568-74. PubMed ID: 11446755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Endoluminal therapy for bilateral malignant ureteric obstruction].
    Liu YD; Yuan J; Huang ST; Luo JT; Zeng GH; Xun L
    Zhonghua Zhong Liu Za Zhi; 2007 Sep; 29(9):717-9. PubMed ID: 18246808
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ureteral stent placement without postprocedural nephrostomy tube: experience in 41 patients.
    Patel U; Abubacker MZ
    Radiology; 2004 Feb; 230(2):435-42. PubMed ID: 14688404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Placement of transileal conduit retrograde nephroureteral stents in patients with ureteral obstruction after cystectomy: technique and outcome.
    Alago W; Sofocleous CT; Covey AM; Thornton RH; Donat SM; Brody LA; Getrajdman GI; Brown KT
    AJR Am J Roentgenol; 2008 Nov; 191(5):1536-9. PubMed ID: 18941097
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retrograde or antegrade double-pigtail stent placement for malignant ureteric obstruction?
    Uthappa MC; Cowan NC
    Clin Radiol; 2005 May; 60(5):608-12. PubMed ID: 15851050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of Galdakao-modified Valdivia position in endoscopic management of malignant ureteric obstruction.
    Emam A; Elmoazen M; Shabayek M; Zriek AM; Gad HH
    Int Urol Nephrol; 2022 Mar; 54(3):463-468. PubMed ID: 35084651
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antegrade double J ureteral stenting for ureteric strictures: use of silicone stents.
    Hoe JW
    Australas Radiol; 1989 Nov; 33(4):385-9. PubMed ID: 2633742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined antegrade and retrograde endoscopic retroperitoneal bypass of ureteric strictures: a modification of the 'rendezvous' procedure.
    Yates DR; Mehta SS; Spencer PA; Parys BT
    BJU Int; 2010 Apr; 105(7):992-7. PubMed ID: 19712115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metallic stents for malignant and benign ureteric obstruction.
    Wakui M; Takeuchi S; Isioka J; Iwabuchi K; Morimoto S
    BJU Int; 2000 Feb; 85(3):227-32. PubMed ID: 10671873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of percutaneous nephrostomy in malignant ureteric obstruction.
    Wilson JR; Urwin GH; Stower MJ
    Ann R Coll Surg Engl; 2005 Jan; 87(1):21-4. PubMed ID: 15720902
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The resonance® metallic ureteric stent in the treatment of chronic ureteric obstruction: a safety and efficacy analysis from a contemporary clinical series.
    Patel C; Loughran D; Jones R; Abdulmajed M; Shergill I
    BMC Urol; 2017 Mar; 17(1):16. PubMed ID: 28283031
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.